STAGE III NSCLC

Clinical trials for STAGE III NSCLC explained in plain language.

Never miss a new study

Get alerted when new STAGE III NSCLC trials appear

Sign up with your email to follow new studies for STAGE III NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New drug strategy aims to shrink tumors before surgery in advanced lung cancer

Disease control Ongoing

This study is testing whether giving the drug lorlatinib before surgery or radiation helps people with stage III non-small cell lung cancer that has a specific genetic change (ALK fusion). About 48 participants will take lorlatinib for three cycles. Doctors will then check if the…

Matched conditions: STAGE III NSCLC

Phase: PHASE2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

STAGE III NSCLC

Get alerted when new STAGE III NSCLC trials appear

New drug strategy aims to shrink tumors before surgery in advanced lung cancer